<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20744" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Dual-Energy X-Ray Absorptiometry</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Krugh</surname>
            <given-names>Marissa</given-names>
          </name>
          <aff>Campbell University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Langaker</surname>
            <given-names>Michelle D.</given-names>
          </name>
          <aff>Campbell University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marissa Krugh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michelle Langaker declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20744.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Dual-energy x-ray absorptiometry has sustained a niche for measuring bone mineral density since its approval by the Food and Drug Administration for clinical use in 1988. The 1998 Bone Mass Measurements Act in solidified its validity compared to other diagnostic modalities. Dual-energy x-ray absorptiometry is comparatively inexpensive, with notably shorter scan times and lower radiation exposure compared to other imaging options. A long-standing international consensus exists regarding guidelines for interpreting dual-energy x-ray absorptiometry images. Specific patient populations are especially at risk of osteoporosis and should be screened according to guidelines. Early detection of osteoporosis through dual-energy x-ray absorptiometry imaging is crucial for halting disease progression and improving patient health through therapeutic interventions. Targeted exercises and physical therapy have proven to be especially effective in slowing and reversing osteoporosis. This activity reviews the indications and limitations of dual-energy x-ray absorptiometry and highlights the interprofessional team's role in&#x000a0;treating patients with osteoporosis.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for dual-energy x-ray absorptiometry.</p></list-item><list-item><p>Assess factors that may cause suboptimal dual-energy x-ray absorptiometry images.</p></list-item><list-item><p>Evaluate the clinical significance of dual-energy x-ray absorptiometry.</p></list-item><list-item><p>Collaborate with the&#x000a0;interprofessional team to manage patients with osteoporosis and improve their outcomes by incorporating dual-energy X-ray absorptiometry results into treatment planning.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20744&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20744">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20744.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Dual-energy x-ray absorptiometry (DEXA) has sustained a niche for measuring bone mineral density (BMD) since its approval by the Food and Drug Administration for clinical use in 1988. The 1998 Bone Mass Measurements Act solidified its validity in light of other diagnostic modalities such as chemical analysis, direct dissection and ashing, quantitative ultrasonography, and computed tomography&#x000a0;or&#x000a0;magnetic resonance imaging. DEXA is relatively&#x000a0;inexpensive, with notably shorter scan times and lower radiation exposure compared to other imaging modalities, and there is a long-standing consensus regarding guidelines for interpreting DEXA images.</p>
        <p>This test is performed using a C-arm with the x-ray source below the supine patient emitting photons at 2 distinct energy levels specific for soft tissue and cortical bone. A collimator is situated between the patient and the x-ray source to minimize scatter. The attenuations from these low- and high-energy photon emissions are detected above the patient and are combined to create a planar image to assess bone mass per unit of area (g/cm&#x000b2;) to determine BMD. A T-score represents&#x000a0;the number of standard deviations between the patient's mean BMD and the population&#x000a0;mean compared&#x000a0;to reference populations matched in gender and race. The Z-score indicates the number of standard deviations above or below the mean&#x000a0;of age-matched controls.</p>
        <p>Volumetric BMD measurements can be obtained from computed tomography scans, including those obtained for unrelated reasons, raising the possibility of retrospective or opportunistic readings to detect asymptomatic osteoporosis. Volumetric BMD is measured in&#x000a0;g/cm&#x000b3; and correlates well with DEXA imaging and other measures of BMD.<xref ref-type="bibr" rid="article-20744.r1">[1]</xref><xref ref-type="bibr" rid="article-20744.r2">[2]</xref></p>
      </sec>
      <sec id="article-20744.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>
<bold>Lumbar Spine</bold>
</p>
        <p>To flatten the lordosis of the lumbar spine, the patient lies supine with their hips and knees flexed on a supportive cushion. A PA film should display the spine as straight as possible, with the visible superior margin of bilateral iliac crests and the central portion of the T12/L5 vertebral body. BMD measurements are obtained using the L1 through L4 vertebral bodies.</p>
        <p>
<bold>Hip</bold>
</p>
        <p>The long axis of the femoral diaphysis is aligned with the scanner as the patient lies supine and a positioning device that internally rotates the femur to elongate the femoral neck on the PA image. If the femur is effectively internally rotated, the lesser trochanter should be barely, if at all, visible. BMD measurements are obtained using the femoral neck, greater trochanter, Ward's area, intertrochanteric region, and total hip.</p>
        <p>
<bold>Forearm</bold>
</p>
        <p>The patient's nondominant arm is placed on the table with the forearm pronated. The image should demonstrate the distal cortex of the radius&#x000a0;and ulna and the diaphysis of each aligned with the long axis of the image. BMD measurements are obtained using the mid to distal radius and ulna.</p>
        <p>
<bold>Whole Body</bold>
</p>
        <p>The patient is placed supine on the table with arms pronated and feet in dorsiflexion. BMD measurements are taken from the upper&#x000a0;or lower extremities and the head.</p>
        <p>
<bold>Choosing Sites for Scanning</bold>
</p>
        <p>Two sites are routinely&#x000a0;evaluated with DEXA&#x02014;the lumbar spine and hip.<xref ref-type="bibr" rid="article-20744.r3">[3]</xref></p>
      </sec>
      <sec id="article-20744.s4" sec-type="Indications">
        <title>Indications</title>
        <p>All women 65&#x000a0;or older and men 70 or older should be screened for asymptomatic osteoporosis.<xref ref-type="bibr" rid="article-20744.r4">[4]</xref></p>
        <p>Women younger than 65 at risk for osteoporosis include the following groups:</p>
        <list list-type="bullet">
          <list-item>
            <p>Those with estrogen deficiency</p>
          </list-item>
          <list-item>
            <p>Those with a history of maternal hip fracture&#x000a0;before 50</p>
          </list-item>
          <list-item>
            <p>Those with low body mass (&#x0003c;127 pounds or body mass index (BMI) &#x0003c;18.5 kg/m&#x000b2;)</p>
          </list-item>
          <list-item>
            <p>Those with a history of amenorrhea&#x000a0;for 1 year or more before 42</p>
          </list-item>
        </list>
        <p>Women younger than 65 or men younger than 70 with the following risk factors should also be screened.</p>
        <list list-type="bullet">
          <list-item>
            <p>Current cigarette smoker</p>
          </list-item>
          <list-item>
            <p>Loss of height</p>
          </list-item>
          <list-item>
            <p>Thoracic kyphosis</p>
          </list-item>
        </list>
        <p>The following groups should also be screened for osteoporosis:</p>
        <list list-type="bullet">
          <list-item>
            <p>Individuals at any age with bone mass osteopenia or fragility fractures on imaging studies.</p>
          </list-item>
          <list-item>
            <p>Individuals 50&#x000a0;or older who develop wrist, hip, spine, or proximal humerus fractures with minimal or no trauma.</p>
          </list-item>
          <list-item>
            <p>Individuals&#x000a0;of any age who develop 1 or more insufficiency fractures.</p>
          </list-item>
          <list-item>
            <p>Individuals receiving (or expected to receive) glucocorticoid therapy equivalent to 5 mg or more of prednisone daily for 3 or more months.</p>
          </list-item>
          <list-item>
            <p>Individuals considering pharmacological therapy for osteoporosis.</p>
          </list-item>
          <list-item>
            <p>Hypogonadal men&#x000a0;18&#x000a0;or older and men with surgically or chemotherapeutically induced castration.</p>
          </list-item>
        </list>
        <p>Medications known to adversely affect BMD include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anticonvulsants</p>
          </list-item>
          <list-item>
            <p>Androgen deprivation therapy</p>
          </list-item>
          <list-item>
            <p>Aromatase inhibitor therapy</p>
          </list-item>
          <list-item>
            <p>Chronic heparin</p>
          </list-item>
        </list>
        <p>Endocrine disorders known to adversely affect BMD include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hyperparathyroidism</p>
          </list-item>
          <list-item>
            <p>Hyperthyroidism</p>
          </list-item>
          <list-item>
            <p>Cushing syndrome</p>
          </list-item>
        </list>
        <p>Patients may be monitored for the following reasons:</p>
        <list list-type="bullet">
          <list-item>
            <p>To assess the effectiveness of osteoporosis drug therapy</p>
          </list-item>
          <list-item>
            <p>Follow-up for medical conditions associated with abnormal BMD</p>
          </list-item>
        </list>
        <p>Children or adolescents with medical conditions associated with abnormal BMD, including but not limited to the following categories:</p>
        <list list-type="bullet">
          <list-item>
            <p>Individuals receiving (or expected to receive) glucocorticoid therapy for more than 3 months</p>
          </list-item>
          <list-item>
            <p>Individuals receiving radiation or chemotherapy for malignancies</p>
          </list-item>
          <list-item>
            <p>Individuals with endocrine disorders known to adversely affect BMD, such as hyperparathyroidism, hyperthyroidism, growth hormone deficiency, or Cushing syndrome</p>
          </list-item>
          <list-item>
            <p>Individuals with bone dysplasias known to have excessive fracture risk, such as osteogenesis imperfecta and osteopetrosis, or high bone density</p>
          </list-item>
        </list>
        <p>Individuals with medical conditions that could decrease BMD include the following conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Chronic renal failure</p>
          </list-item>
          <list-item>
            <p>Rheumatoid arthritis and other inflammatory arthritides</p>
          </list-item>
          <list-item>
            <p>Eating disorders, including anorexia nervosa and bulimia</p>
          </list-item>
          <list-item>
            <p>Organ transplantation</p>
          </list-item>
          <list-item>
            <p>Prolonged immobilization</p>
          </list-item>
          <list-item>
            <p>History of a gastric bypass for obesity (noting that the accuracy of DEXA in these patients might be affected by obesity)</p>
          </list-item>
          <list-item>
            <p>Conditions associated with secondary osteoporosis, such as gastrointestinal malabsorption, inflammatory bowel disease, malnutrition, osteomalacia, vitamin D deficiency, acromegaly, cirrhosis, HIV infection, chronic alcoholism, and multiple myeloma.</p>
          </list-item>
        </list>
        <p>DEXA may be indicated in the diagnosis, staging, and follow-up of individuals with conditions that result in pathologically increased BMD, such as osteopetrosis or prolonged exposure to fluoride.</p>
        <p>DEXA may be indicated as a tool to measure regional and whole-body fat and lean mass, such as in patients with malabsorption, cancer, or eating disorders.</p>
      </sec>
      <sec id="article-20744.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>There are no absolute contraindications for performing DEXA. The&#x000a0;possibility of inadequate studies or the need for modification of the technique or rescheduling of the DEXA test may be required in the following situations:</p>
        <list list-type="bullet">
          <list-item>
            <p>Recently administered gastrointestinal contrast or radionuclides</p>
          </list-item>
          <list-item>
            <p>Pregnancy</p>
          </list-item>
          <list-item>
            <p>Scoliosis, which may affect spine measurements</p>
          </list-item>
          <list-item>
            <p>Severe degenerative changes or fracture deformity in the measurement area</p>
          </list-item>
          <list-item>
            <p>Implants, hardware, devices, or other foreign material in the measurement area</p>
          </list-item>
          <list-item>
            <p>The patient's inability to attain the correct position or remain motionless for the measurement</p>
          </list-item>
          <list-item>
            <p>Extremes of high or low BMI may adversely affect the ability to obtain accurate and precise measurements. Quantitative computed tomography (QCT) may be a desirable alternative for these individuals.</p>
          </list-item>
          <list-item>
            <p>Any condition that precludes proper positioning of the patient to be able to&#x000a0;obtain accurate BMD values</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20744.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>A DEXA scan is&#x000a0;typically&#x000a0;performed using a C-arm with an x-ray source that allows for variable photon energy levels, a collimator, a detector, and associated computer software.</p>
      </sec>
      <sec id="article-20744.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>DEXA imaging is&#x000a0;typically&#x000a0;performed by&#x000a0;radiologic&#x000a0;or nuclear medicine technologists under the supervision of a licensed physician.</p>
      </sec>
      <sec id="article-20744.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>
<bold>Pre-Scan Discussion</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients should be able to tolerate laying on the back for up to 10 minutes.</p>
          </list-item>
          <list-item>
            <p>Patients who weigh more than 300 pounds require alternative BMD testing. Different models have different weight restrictions, and the equipment limitations should be checked.</p>
          </list-item>
          <list-item>
            <p>Recent medical imaging with contrast, such as barium or gadolinium, precludes imaging for 2 weeks after contrast is administered.</p>
          </list-item>
          <list-item>
            <p>Premenopausal patients should be asked whether there is any possibility that&#x000a0;they might be pregnant. A pregnancy test may need to be administered before the examination.</p>
          </list-item>
          <list-item>
            <p>Calcium tablets should not be taken&#x000a0;within&#x000a0;24 hours before the examination.</p>
          </list-item>
          <list-item>
            <p>Patients should wear comfortable, loose-fitting clothes,&#x000a0;avoiding metal components such as zippers.</p>
          </list-item>
          <list-item>
            <p>If a prior DEXA was done, the patient should be instructed to bring results.</p>
          </list-item>
          <list-item>
            <p>For body composition studies, patients should be scanned in the morning after a 12-hour overnight fast for consistency.</p>
          </list-item>
        </list>
        <p>
<bold>Examination Day Discussion</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Compliance with the above-listed recommendations should be ensured.</p>
          </list-item>
          <list-item>
            <p>The menopausal status should be re-checked, and negative pregnancy status should be confirmed.</p>
          </list-item>
          <list-item>
            <p>Subjects should be dressed in hospital gowns or scrubs, wearing only underpants and, if necessary, thin socks. A thin sheet may be placed over them for warmth.</p>
          </list-item>
          <list-item>
            <p>All radio-opaque objects should be removed from the scan area.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20744.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>Interpretation of Results</bold>
</p>
        <p>BMD is the standard for measuring the diagnosis of osteoporosis and fracture risk assessment. The Fracture Risk Assessment Tool (FRAX) uses clinical risk factors, excluding the measure of BMD, to identify individuals at risk for osteoporosis or fractures. The FRAX was implemented in 2008 by the World Health Organization (WHO) and is used to calculate the chance of a fracture in a 10-year timeframe.</p>
        <p>The clinical risk factors included in FRAX are age, sex, race, height, weight, BMI, a history of fracture, use of oral glucocorticoids, rheumatoid arthritis, other secondary causes of osteoporosis, smoking, and alcohol&#x000a0;use of 3 or more drinks daily. The geographic location of a patient's home is also considered in the calculation.</p>
        <p>In the United States, the National Osteoporosis Foundation recommends using FRAX to calculate fracture risk for patients with T-scores between &#x02212;1.0 and &#x02212;2.5 in the spine, femoral neck, or total hip region.</p>
        <p>A licensed radiologist interprets the scans, and a T-score is determined to evaluate the standard deviation in the mean from the reference population and the patient's average BMD. The WHO defines T-scores as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Greater than or equal to &#x02212;1.0: normal</p>
          </list-item>
          <list-item>
            <p>Between &#x02212;1.0 and &#x02212;2.5: osteopenia</p>
          </list-item>
          <list-item>
            <p>Less than or equal to &#x02212;2.5: osteoporosis</p>
          </list-item>
          <list-item>
            <p>Less than or equal to &#x02212;2.5 plus fragility fracture: severe osteoporosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20744.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Complications are uncommon with this procedure. The radiation dose is comparable to standard background radiation.</p>
      </sec>
      <sec id="article-20744.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>DEXA imaging plays a crucial role in evaluating osteoporosis. The International Society of Clinical Densitometry, the United States Preventative Services Task Force, and the National Osteoporosis Foundation recommend that all women over 65 have a BMD evaluation. DEXA imaging&#x000a0;is the gold standard for diagnosing osteoporosis and predicting fracture risk with algorithms such as the FRAX. Although DEXA imaging has excellent reported accuracy and precision, consideration should be made when<bold>&#x000a0;</bold>comparing results across different instruments from different manufacturers unless cross-calibration has been assured.&#x000a0;</p>
        <p>DEXA imaging is the best clinical tool for assessing BMD in the evaluation of osteoporosis, and its validity is evident, given its ubiquity among international guidelines.</p>
        <p>Evaluation of primary and secondary osteoporosis cannot be elucidated with DEXA imaging. This&#x000a0;limitation was exemplified in&#x000a0;a study showing that 55 out of 173 women (32%) diagnosed with primary osteoporosis were found to have secondary causes, most often calcium disorders and hyperparathyroidism. The study suggested that additional testing for all women,&#x000a0;including 24-hour urine calcium, serum calcium, serum parathyroid hormone,&#x000a0;and serum thyroid-stimulating hormone for women on thyroid replacement therapy,&#x000a0;is cost-effective in identifying secondary causes of osteoporosis.<xref ref-type="bibr" rid="article-20744.r5">[5]</xref></p>
      </sec>
      <sec id="article-20744.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The collaboration of the interprofessional healthcare team&#x000a0;is crucial to ensure the appropriate DEXA test is ordered and performed correctly. According to ACR Appropriateness Criteria Osteoporosis and Bone Mineral Density, there are specific cases in which QCT is considered superior to DEXA. These include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Extremes in body height,&#x000a0;such as very large and very small patients</p>
          </list-item>
          <list-item>
            <p>Patients with extensive degenerative disease of the spine</p>
          </list-item>
          <list-item>
            <p>Severely obese patients (BMI &#x0003e;35 kg/m&#x000b2;)</p>
          </list-item>
          <list-item>
            <p>A clinical scenario that requires increased sensitivity to small changes in trabecular bone density (parathyroid hormone and glucocorticoid treatment monitoring)&#x000a0;<xref ref-type="bibr" rid="article-20744.r3">[3]</xref></p>
          </list-item>
        </list>
        <p>Pitfalls in DEXA are common, and errors can be categorized as patient positioning, data analysis, artifacts, or demographics. Structural changes, such as osteophytes, calcifications, or fractures, are more common in the lumbar spine compared to in the proximal femur and potentially cause an artefactual component of BMD.<xref ref-type="bibr" rid="article-20744.r6">[6]</xref>&#x000a0;Patient positioning may have the consequences of missing important anatomical regions, or excessive internal or external rotation of the proximal femur may cause non-negligible changes in BMD values.<xref ref-type="bibr" rid="article-20744.r7">[7]</xref>&#x000a0;Artifacts such as bra components, surgical clips, navel rings, and vascular prostheses may alter the final BMD, resulting in overestimation if the metal is included in the region of interest or underestimation if it is outside the region of interest.<xref ref-type="bibr" rid="article-20744.r8">[8]</xref>&#x000a0;Errors in assigning demographics are significant because the T-score is correlated to reference populations in gender and race. Some of the pitfalls can be avoided; however, some are unavoidable and must be considered by the healthcare team.</p>
      </sec>
      <sec id="article-20744.s13" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>The DEXA scan should be used as a decision-making tool for Allied Health Professionals, such as physical and occupational therapists.<xref ref-type="bibr" rid="article-20744.r9">[9]</xref>&#x000a0;The multi-component training consists of a combination of different exercises, such as aerobics, strengthening, progressive resistance, balancing, and dancing, aimed at increasing and preserving bone mass.<xref ref-type="bibr" rid="article-20744.r10">[10]</xref></p>
        <p>Several types of exercise are recommended for patients&#x000a0;with osteoporosis to counter bone mass reduction.<xref ref-type="bibr" rid="article-20744.r11">[11]</xref>&#x000a0;Combining multiple types of exercise can significantly affect BMD at three sites&#x02014;the femoral neck, greater trochanter, and especially the spine.</p>
        <p>A&#x000a0;meta-analysis of&#x000a0;postmenopausal women found that resistance training increased lumbar BMD, and adding low-moderate impact exercises such as jogging, walking, and stair climbing was even more effective in preserving BMD at both lumbar and femoral levels.<xref ref-type="bibr" rid="article-20744.r12">[12]</xref><xref ref-type="bibr" rid="article-20744.r13">[13]</xref>&#x000a0;Another study involving older and middle-aged men showed that resistance training and load-bearing exercise improved bone mass density rather than just decreasing the loss.&#x000a0;A suggested exercise frequency is 3 or more&#x000a0;sessions between 30 and 60 minutes each for at least 10 months to show BMD improvement.<xref ref-type="bibr" rid="article-20744.r14">[14]</xref></p>
      </sec>
      <sec id="article-20744.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20744&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20744">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20744/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20744">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20744.s15">
        <title>References</title>
        <ref id="article-20744.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koch</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hokamp</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Albrecht</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Gruenewald</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Yel</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Borggrefe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wesarg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eichler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Burck</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gruber-Rouh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lenga</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vogl</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Wichmann</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hammerstingl</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Alizadeh</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Mader</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huizinga</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>D'Angelo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ascenti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mazziotti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Booz</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Accuracy and precision of volumetric bone mineral density assessment using dual-source dual-energy versus quantitative CT: a phantom study.</article-title>
            <source>Eur Radiol Exp</source>
            <year>2021</year>
            <month>Oct</month>
            <day>05</day>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <pub-id pub-id-type="pmid">34608576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tabensky</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>DeLuca</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Briganti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Seeman</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Bone mass, areal, and volumetric bone density are equally accurate, sensitive, and specific surrogates of the breaking strength of the vertebral body: an in vitro study.</article-title>
            <source>J Bone Miner Res</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>11</volume>
            <issue>12</issue>
            <fpage>1981</fpage>
            <page-range>1981-8</page-range>
            <pub-id pub-id-type="pmid">8970902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Expert Panel on Musculoskeletal Imaging:</collab>
              <name>
                <surname>Ward</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Bencardino</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baccei</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Cassidy</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Greenspan</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Gyftopoulos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hochman</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Mintz</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Reitman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>ZS</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Small</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Weissman</surname>
                <given-names>BN</given-names>
              </name>
            </person-group>
            <article-title>ACR Appropriateness Criteria<sup>&#x000ae;</sup> Osteoporosis&#x000a0;and&#x000a0;Bone Mineral Density.</article-title>
            <source>J Am Coll Radiol</source>
            <year>2017</year>
            <month>May</month>
            <volume>14</volume>
            <issue>5S</issue>
            <fpage>S189</fpage>
            <page-range>S189-S202</page-range>
            <pub-id pub-id-type="pmid">28473075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r4">
          <label>4</label>
          <element-citation publication-type="book">
            <source>Osteoporosis: assessing the risk of fragility fracture</source>
            <publisher-name>National Institute for Health and Care Excellence (NICE)</publisher-name>
            <publisher-loc>London</publisher-loc>
            <year>2017</year>
            <month>02</month>
            <pub-id pub-id-type="pmid">32186835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tannenbaum</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schwartzman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wallenstein</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lapinski</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Meier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Luckey</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>87</volume>
            <issue>10</issue>
            <fpage>4431</fpage>
            <page-range>4431-7</page-range>
            <pub-id pub-id-type="pmid">12364413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Preidler</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Tashkin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McDaniel</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Brossmann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andresen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sartoris</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Dual-energy X-ray absorptiometric densitometry in osteoarthritis of the hip. Influence of secondary bone remodeling of the femoral neck.</article-title>
            <source>Acta Radiol</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>4 Pt 1</issue>
            <fpage>539</fpage>
            <page-range>539-42</page-range>
            <pub-id pub-id-type="pmid">9240674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lekamwasam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lenora</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Effect of leg rotation on hip bone mineral density measurements.</article-title>
            <source>J Clin Densitom</source>
            <year>2003</year>
            <season>Winter</season>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>331</fpage>
            <page-range>331-6</page-range>
            <pub-id pub-id-type="pmid">14716045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watts</surname>
                <given-names>NB</given-names>
              </name>
            </person-group>
            <article-title>Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA).</article-title>
            <source>Osteoporos Int</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>15</volume>
            <issue>11</issue>
            <fpage>847</fpage>
            <page-range>847-54</page-range>
            <pub-id pub-id-type="pmid">15322740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benedetti</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Furlini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Letizia Mauro</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The Effectiveness of Physical Exercise on Bone Density in Osteoporotic Patients.</article-title>
            <source>Biomed Res Int</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>4840531</fpage>
            <pub-id pub-id-type="pmid">30671455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hopewell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Adedire</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Copsey</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Boniface</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Sherrington</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Clemson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Close</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Lamb</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Multifactorial and multiple component interventions for preventing falls in older people living in the community.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2018</year>
            <month>Jul</month>
            <day>23</day>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>CD012221</fpage>
            <pub-id pub-id-type="pmid">30035305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Kam</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Smulders</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Weerdesteyn</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Smits-Engelsman</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <article-title>Exercise interventions to reduce fall-related fractures and their risk factors in individuals with low bone density: a systematic review of randomized controlled trials.</article-title>
            <source>Osteoporos Int</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>20</volume>
            <issue>12</issue>
            <fpage>2111</fpage>
            <page-range>2111-25</page-range>
            <pub-id pub-id-type="pmid">19421702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nikander</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Siev&#x000e4;nen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Heinonen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Uusi-Rasi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kannus</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Targeted exercise against osteoporosis: A systematic review and meta-analysis for optimising bone strength throughout life.</article-title>
            <source>BMC Med</source>
            <year>2010</year>
            <month>Jul</month>
            <day>21</day>
            <volume>8</volume>
            <fpage>47</fpage>
            <pub-id pub-id-type="pmid">20663158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martyn-St James</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Effects of different impact exercise modalities on bone mineral density in premenopausal women: a meta-analysis.</article-title>
            <source>J Bone Miner Metab</source>
            <year>2010</year>
            <month>May</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>251</fpage>
            <page-range>251-67</page-range>
            <pub-id pub-id-type="pmid">20013013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20744.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolam</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>van Uffelen</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Taaffe</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>The effect of physical exercise on bone density in middle-aged and older men: a systematic review.</article-title>
            <source>Osteoporos Int</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>11</issue>
            <fpage>2749</fpage>
            <page-range>2749-62</page-range>
            <pub-id pub-id-type="pmid">23552825</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
